SULT2B1 and colitis: In contrast, there was no difference among Sult2b1+/+Dock2+/+, Sult2b1+/+Dock2−/−, and Sult2b1−/−Dock2−/− mice in the degree of weight loss (Figure 3G), indicating that CS alleviates DSS-induced colitis by inhibiting DOCK2.